OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
High fibrosis-4 index predicts the new onset of ischaemic heart disease during a 10-year period in a general population
Yukimura Higashiura, Marenao Tanaka, Kazuma Mori, et al.
European Heart Journal Open (2022) Vol. 2, Iss. 3
Open Access | Times Cited: 18
Yukimura Higashiura, Marenao Tanaka, Kazuma Mori, et al.
European Heart Journal Open (2022) Vol. 2, Iss. 3
Open Access | Times Cited: 18
Showing 18 citing articles:
Coexistence of Metabolic Dysfunction‐Associated Fatty Liver Disease and Chronic Kidney Disease Is a More Potent Risk Factor for Ischemic Heart Disease
Daisuke Miyamori, Marenao Tanaka, Tatsuya Sato, et al.
Journal of the American Heart Association (2023) Vol. 12, Iss. 14
Open Access | Times Cited: 17
Daisuke Miyamori, Marenao Tanaka, Tatsuya Sato, et al.
Journal of the American Heart Association (2023) Vol. 12, Iss. 14
Open Access | Times Cited: 17
Deciphering metabolic dysfunction‐associated steatotic liver disease: insights from predictive modeling and clustering analysis
Kazuma Mori, Yukinori Akiyama, Marenao Tanaka, et al.
Journal of Gastroenterology and Hepatology (2024) Vol. 39, Iss. 7, pp. 1382-1393
Open Access | Times Cited: 8
Kazuma Mori, Yukinori Akiyama, Marenao Tanaka, et al.
Journal of Gastroenterology and Hepatology (2024) Vol. 39, Iss. 7, pp. 1382-1393
Open Access | Times Cited: 8
Metabolic dysfunction-associated fatty liver disease is associated with an increase in systolic blood pressure over time: linear mixed-effects model analyses
Kazuma Mori, Marenao Tanaka, Itaru Hosaka, et al.
Hypertension Research (2023) Vol. 46, Iss. 5, pp. 1110-1121
Closed Access | Times Cited: 16
Kazuma Mori, Marenao Tanaka, Itaru Hosaka, et al.
Hypertension Research (2023) Vol. 46, Iss. 5, pp. 1110-1121
Closed Access | Times Cited: 16
Predictive value of the Framingham steatosis index for cardiovascular risk: a nationwide population-based cohort study
Yun Kyung Cho, Myungjin Kim, Ye‐Jee Kim, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 10
Yun Kyung Cho, Myungjin Kim, Ye‐Jee Kim, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 10
Liver stiffness as a cornerstone in heart disease risk assessment
Joost Boeckmans, Laurent Sandrin, Christian Knackstedt, et al.
Liver International (2023) Vol. 44, Iss. 2, pp. 344-356
Open Access | Times Cited: 10
Joost Boeckmans, Laurent Sandrin, Christian Knackstedt, et al.
Liver International (2023) Vol. 44, Iss. 2, pp. 344-356
Open Access | Times Cited: 10
Sudden cardiac death associated with fatty liver disease
Jonathan Vo, Thien Tan Tri Tai Truyen, Audrey Uy‐Evanado, et al.
IJC Heart & Vasculature (2025) Vol. 56, pp. 101602-101602
Open Access
Jonathan Vo, Thien Tan Tri Tai Truyen, Audrey Uy‐Evanado, et al.
IJC Heart & Vasculature (2025) Vol. 56, pp. 101602-101602
Open Access
Verification of the Short-Term Impact of Imeglimin on Liver Fibrosis Markers Stratified by Liver Fibrosis Risk in Patients With Type 2 Diabetes
Takumi Tanaka, Takashi Kitao, Motohiro Kubori, et al.
Cureus (2025)
Open Access
Takumi Tanaka, Takashi Kitao, Motohiro Kubori, et al.
Cureus (2025)
Open Access
Association between liver fibrosis, plasma volume status, and cardiovascular mortality: The Hiroshima Study on Glucose Metabolism and Cardiovascular Diseases
Nobuo Sasaki, Yoshitaka Ueno, Ryoji Ozono, et al.
European Journal of Heart Failure (2025)
Closed Access
Nobuo Sasaki, Yoshitaka Ueno, Ryoji Ozono, et al.
European Journal of Heart Failure (2025)
Closed Access
High fatty liver index is an independent predictor of ischemic heart disease during a 10‐year period in a Japanese population
Kazuma Mori, Marenao Tanaka, Yukimura Higashiura, et al.
Hepatology Research (2022) Vol. 52, Iss. 8, pp. 687-698
Closed Access | Times Cited: 13
Kazuma Mori, Marenao Tanaka, Yukimura Higashiura, et al.
Hepatology Research (2022) Vol. 52, Iss. 8, pp. 687-698
Closed Access | Times Cited: 13
Probiotics may be useful for drug-induced liver dysfunction in patients with depression – A secondary analysis of a randomized clinical trial
Oliwia Gawlik-Kotelnicka, Jacek Burzyński, Jakub Rogalski, et al.
Clinical Nutrition ESPEN (2024) Vol. 63, pp. 604-614
Open Access | Times Cited: 2
Oliwia Gawlik-Kotelnicka, Jacek Burzyński, Jakub Rogalski, et al.
Clinical Nutrition ESPEN (2024) Vol. 63, pp. 604-614
Open Access | Times Cited: 2
An Update on the Effect Of Sodium Glucose Cotransporter 2 Inhibitors on Non-Alcoholic Fatty Liver Disease: A Systematic Review of Clinical Trials
Abdulrahman I. Alfayez, Jawaher M. Alfallaj, Mugahid A. Mobark, et al.
Current Diabetes Reviews (2023) Vol. 20, Iss. 2
Closed Access | Times Cited: 4
Abdulrahman I. Alfayez, Jawaher M. Alfallaj, Mugahid A. Mobark, et al.
Current Diabetes Reviews (2023) Vol. 20, Iss. 2
Closed Access | Times Cited: 4
Nutritional patterns as machine learning predictors of liver health in a population of elderly subjects
Luisa Lampignano, Rossella Tatoli, Rossella Donghia, et al.
Nutrition Metabolism and Cardiovascular Diseases (2023) Vol. 33, Iss. 11, pp. 2233-2241
Closed Access | Times Cited: 4
Luisa Lampignano, Rossella Tatoli, Rossella Donghia, et al.
Nutrition Metabolism and Cardiovascular Diseases (2023) Vol. 33, Iss. 11, pp. 2233-2241
Closed Access | Times Cited: 4
The correlation of shift work and CLOCK, BMAL1, and PER1 gene polymorphisms with hypertension in healthcare workers: A cross-sectional study
Min Qiang, Wang Hu, Dan Lei, et al.
Medicine (2024) Vol. 103, Iss. 47, pp. e40148-e40148
Open Access | Times Cited: 1
Min Qiang, Wang Hu, Dan Lei, et al.
Medicine (2024) Vol. 103, Iss. 47, pp. e40148-e40148
Open Access | Times Cited: 1
Association between Coronary Artery Plaque Progression and Liver Fibrosis Biomarkers in Population with Low Calcium Scores
Tsung‐Ying Tsai, Pai‐Feng Hsu, Cheng‐Hsueh Wu, et al.
Nutrients (2022) Vol. 14, Iss. 15, pp. 3163-3163
Open Access | Times Cited: 6
Tsung‐Ying Tsai, Pai‐Feng Hsu, Cheng‐Hsueh Wu, et al.
Nutrients (2022) Vol. 14, Iss. 15, pp. 3163-3163
Open Access | Times Cited: 6
Liver fibrosis and retinal features in an older Mediterranean population: Results from the Salus in Apulia study
Luisa Lampignano, Alfredo Niro, Fabio Castellana, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 5
Luisa Lampignano, Alfredo Niro, Fabio Castellana, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 5
Liver Fibrosis as an Independent Cardiovascular Risk Factor in Non-alcoholic Fatty Liver Disease
Dmitry Victorovich Garbuzenko
Journal of Translational Gastroenterology (2024) Vol. 2, Iss. 1, pp. 21-29
Open Access
Dmitry Victorovich Garbuzenko
Journal of Translational Gastroenterology (2024) Vol. 2, Iss. 1, pp. 21-29
Open Access
PREDICTIVE VALUE OF FIBROSIS-4 INDEX FOR HIGHER TROPONIN LEVELS IN ACUTE CORONARY SYNDROME
Hüseyin Durak, Elif Ergül
Kırıkkale Üniversitesi Tıp Fakültesi Dergisi (2024) Vol. 26, Iss. 1, pp. 34-41
Open Access
Hüseyin Durak, Elif Ergül
Kırıkkale Üniversitesi Tıp Fakültesi Dergisi (2024) Vol. 26, Iss. 1, pp. 34-41
Open Access
Fibrosis-4 index is closely associated with future development of hypertension in the Japanese general population
Sumiyo Yamashita, Hiroyuki Takase, Naomi Kawakatsu, et al.
Hypertension Research (2024)
Closed Access
Sumiyo Yamashita, Hiroyuki Takase, Naomi Kawakatsu, et al.
Hypertension Research (2024)
Closed Access
